Etiology and Management of Atrial Fibrillation in Sick Sinus Syndrome

Shared Pathophysiological Mechanism

The American College of Cardiology and other guideline societies suggest that age-dependent, progressive, degenerative fibrosis affects both the sinus nodal tissue and the surrounding atrial myocardium, contributing to the development of atrial fibrillation in patients with sick sinus syndrome, with a strength of evidence based on multiple studies 2, 3, 1
Patchy atrial fibrosis juxtaposed with normal atrial fibers creates nonhomogeneous conduction that promotes both sinus node dysfunction and atrial fibrillation, as reported in the Circulation journal 2, 3
Atrial tissue demonstrates loss of atrial muscle mass, myocyte hypertrophy, myocyte size variation, myocyte disorganization, myocytolysis, and interstitial mononuclear cell proliferation in patients with sick sinus syndrome, according to a study published in Circulation 4
Extracellular matrix remodeling, including upregulation of matrix metalloproteinase 2 (MMP-2) and type 1 collagen, is associated with sustained atrial fibrillation, as noted in studies published in Circulation and the Journal of the American College of Cardiology 2, 3

Tachy-brady syndrome occurs when the same degenerative fibrosis responsible for bradycardia also causes the development of atrial arrhythmias, representing a specific subtype of sick sinus syndrome, as described in Praxis Medical Insights 1

The American College of Cardiology recommends permanent pacemaker implantation as the definitive treatment for symptomatic sick sinus syndrome, including tachy-brady syndrome, with a high strength of evidence 1, 5
Physiological pacing (atrial or dual-chamber) is superior to VVI pacing for sinus node dysfunction, as reported in Praxis Medical Insights 1, 5
Atrial-based rate-responsive pacing is preferred to minimize exertion-related symptoms, according to Praxis Medical Insights 1, 5
Despite adequate pacing, syncope recurs in approximately 20% of patients during long-term follow-up due to associated vasodepressor reflex mechanisms, as noted in Praxis Medical Insights 1, 5

Catheter ablation may be considered for atrial tachyarrhythmia control in tachy-brady syndrome, as suggested in Praxis Medical Insights 1, 5
Catheter ablation is the first-choice treatment for paroxysmal AV nodal reciprocating tachycardia, AV reciprocating tachycardia, or typical atrial flutter, according to Praxis Medical Insights 5

Medications that exacerbate bradycardia must be eliminated when possible before attributing symptoms solely to intrinsic disease, as recommended in Praxis Medical Insights 1, 5
Beta-blockers are contraindicated in patients with sick sinus syndrome, as noted in Praxis Medical Insights 5
Non-dihydropyridine calcium channel blockers (diltiazem, verapamil) are contraindicated in sick sinus syndrome except in the presence of a functioning ventricular pacemaker, according to Praxis Medical Insights 5
Cardiac glycosides, membrane-active antiarrhythmic agents, and Class IC antiarrhythmics can exacerbate or unmask underlying sinus node dysfunction, as reported in Praxis Medical Insights 1